New funding for Ebola hides an ongoing decline

A new report gives the first ever picture of global investment in Ebola R&D, reporting that this investment might have come at the expense of efforts to develop health technologies for other neglected diseases. The report found that $3.4 billion was invested in neglected disease R&D in 2014. New funding for Ebola R&D was entirely responsible for the $150 million increase in neglected disease R&D funding in 2014, with funding for all other neglected diseases down 0.4 percent.

Read more 0 Comments